logo-loader
NYSE:SVA

Sinovac Biotech

Receive alerts
Market:
NYSE
Market Cap:
$482.2 m
Price
$6.78
Change
11.79%
52 weeks high
8.46
52 weeks low
5.98

In brief

Sinovac Biotech (also known in China as Beijing Kexing Bioproducts) specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepatitis A and Hepatitis B, influenza and “SARS”. Sinovac is one of the leading emerging biotechnology companies in China.